视网膜母细胞瘤综合治疗及分子靶向治疗展望(2)
 |
| 第1页 |
参见附件(2656KB，2页)。
[6]梁建宏，黎晓新，尹虹，等。视网膜母细胞瘤患者全身化疗药物治疗联合眼部治疗的临床疗效观察。中华眼底病杂志，2007,23-332-335.
[7] Shields CL,Shields JA, Cater J,et al.Development of new retinoblastomas following six cycles of chemoreduction for retinoblastoma in 162 eyes of 106
consecutive patients. Arch Ophthalmol ,2003,121:1571-1576.
[8]Xu HJ.Retinoblastoma and tumor-suppressor gene therapy.Ophthalmol ClinNorthAm,2003,16:621-629.
[9]MadreperlaSA,Whittum-HudsonJA,PrendergastRA,etal.Intraoculartumor suppression of retinblastoma gene-reconstituted retinoblastomacells.Cancer Res,1991,5:6381-6384.
[10]AdachiM, BrooksSE, SteinMR, etal. Destruction ofhuman retino-Blastoma after treatment by the Evariant of encephalomy ocarditisvirus. Jneurooncol
2006; 77(3):233-240.
[11]Wadhwa L, HurwitzMY, Chévez-BarriosP, etal. Treatmentof in-vasive retinoblastoma in a murine model using an oncolytic picornavir-us.
CancerRes2007; 67(22): 10653-10656.
[12]Elison JR, CobrinikD, ClarosN, etal. Smallmolecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells. Arch Ophthalmol 2006;124(9):1269-1275.
您现在查看是摘要介绍页，详见PDF附件(2656KB，2页)。